You are here: Industry Insights > COVID-19

News List

Calls for better integration of allied health solutions to prevent increase in chronic conditions, as hundreds likely to suffer long-term effects of COVID-19 prnasia
October 15, 2020
University health experts are calling for better recognition of allied health professionals to aid the nation's post-COVID-19 economic and social recovery, with research showing hundreds of Australians could be affected by chronic health problems ...
BioGX Announces FDA Emergency Use Authorization Submission of Extraction-Free Direct RT-PCR Test for COVID-19 prnasia
October 15, 2020
BioGX, a molecular diagnostics solutions company, announced FDA Emergency Use Authorization (EUA) submission of an extraction-free, direct sample addition RT-PCR test for detection of SARS-CoV-2 viral RNA in patients suspected of COVID-19.
COVID-19 Long-Acting AntiBody (LAAB) combination AZD7442 rapidly advances into Phase III clinical trials worldpharmanews
October 14, 2020
AstraZeneca's long-acting antibody (LAAB) combination, AZD7442, will advance into two Phase III clinical trials in more than 6,000 participants at sites in and outside the US that are due to begin in the this weeks.
Mask mandates shown to significantly reduce spread of COVID-19 worldpharmanews
October 14, 2020
A new study by Simon Fraser University (SFU) researchers has found clear evidence that wearing a mask can have a significant impact on the spread of COVID-19.
UK to commence anti-TB BCG vaccine trials to test efficacy against COVID-19 expresspharma
October 14, 2020
Previous studies suggest that the BCG vaccine could reduce susceptibility to a range of infections caused by viruses including those similar to the novel coronavirus causing COVID-19.
AstraZeneca secures $486m from US for Covid-19 antibody pharmaceutical-technology
October 14, 2020
AstraZeneca has received an investment of approximately $486m from the US Government to develop and supply its long-acting antibody (LAAB) cocktail, AZD7442, for Covid-19 treatment.
ARCA Announces IND Application Approval for Potential COVID-19 Treatment americanpharmaceuticalreview
October 14, 2020
ARCA biopharma announced the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for AB201 (rNAPc2) as a potential treatment for patients hospitalized with COVID-19.
Lilly Provides Update on SARS-CoV-2 Neutralizing Antibody Programs americanpharmaceuticalreview
October 14, 2020
Eli Lilly and Company announced additional details on its SARS-CoV-2 neutralizing antibody programs – including interim data on combination therapy in recently diagnosed patients with mild-to-moderate COVID-19 – and plans to make these therapies ...
Opaganib COVID-19 Study Passes Second Independent Committee Review americanpharmaceuticalreview
October 14, 2020
RedHill Biopharma announced the U.S. Phase 2 study with opaganib (Yeliva?, ABC294640) in patients hospitalized with severe COVID-19 pneumonia has passed its second pre-scheduled safety review by the independent Safety Monitoring Committee (SMC) with a ...
Abbott Releases ID NOW COVID-19 Interim Clinical Study Results americanpharmaceuticalreview
October 14, 2020
In a continuing effort to provide the facts about ID NOW to support public health interests, Abbott is sharing new interim clinical data results on its ID NOW COVID-19 rapid test.